|
 Prime Minister Narendra Modi has launched the Advanced Level Research Centre (ALRC) of the Indian Pharmacopoeia Commission (IPC) to boost pharmaceutical research and development. The event marks the establishment of a state-of-the-art laboratory facility dedicated to advancing standards and research in the pharmaceutical sector.
Constructed at a cost of Rs. 49 crore, the ALRC is well equipped with modern infrastructure and facilities to support high-quality research and training programs. This also signifies a step towards elevating Indian pharmaceuticals to a higher level in the global market, thereby contributing to the growth of the Indian pharma industry as a whole.
Drugs Controller General of India (DCGI) Dr. Rajeev Raghuvanshi and his team at IPC were lauded for their dedication and efforts in realizing this milestone. IPC team members expressed their support, emphasizing the pivotal role this center would play in elevating Indian pharmaceuticals to greater heights on the global stage. With aspirations to enhance standards and drive innovation, the IPC aims to propel the Indian pharma industry to new levels of success in the years to come.
The PM virtually inaugurated the ALRC at IPC, Ghaziabad from Rajkot, Gujarat. This happened in presence of Dr. Mansukh Mandaviya, Union minister of health and family welfare and chemicals and fertilizers, Prof S P Singh Baghel, Union minister of state of health and family welfare, Dr. Bharati Pravin Pawar, Union minister of state of health and family welfare and ministry of tribal affairs. General (Dr) V K Singh (Retd.), Union minister of state for civil aviation, road transport and highways was physically present at IPC, Ghaziabad.
Speaking on the occasion, General (Dr) V K Singh congratulated IPC on completion and inauguration of ALRC which will serve as a testament to IPC's commitment to advancing pharmaceutical research and development in India. “ALRC will serve the nation as a hub for cutting-edge research, innovation, and training in the field of pharmacopoeia standards-setting, pharmacovigilance, and other allied areas,” he added.
General Singh also took a tour of the ALRC and encouraged IPC scientists for carrying out innovative work to solve the key problems and obstacles in the pharmaceutical standardization. This will make the basis for ensuring availability of high quality and safe medicines at affordable costs in India.
|